StreetAlpha.app
Home › Stocks › MED

Medifast Inc (MED)

$11.75
▼ −1.92%
LAST CLOSE · NOV 20

Medifast Inc (MED) tracked by StreetAlpha. It last closed at $11.75 on Nov 20, down 1.92% on the day. The next earnings report for MED is expected around Tue, Feb 16, 2027, after the close. For the quarter ended Sep 2026, MED reported EPS of -$1.57 on revenue of $72.0M, with revenue down 19.4% from a year ago. Over its last 8 reports the stock moved an average of 9.5% the session after earnings. Over the last 12 months MED insiders bought $2.9M of stock on the open market and sold $226K, according to SEC Form 4 filings.

AI Auto Pilots
Is MED in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold MED.

Key Stats

Last 12 months
Results
Revenue
$299.6M
−30.3% vs a year ago
Net income
−$40.9M
−16572.6% vs a year ago
EPS (diluted)
−$3.70
−18600.0% vs a year ago
Free cash flow
−$3.9M
−1.3% margin
Valuation
Market cap
$131.4M
11.2M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$58.4M
At Sep 30
Shareholder equity
$180.3M
Shares outstanding
11.2M
At Oct 19
Fiscal year endsDecember
ExchangeNYSE
Financials history
FY2021: $1.5B$1.5BFY2021FY2022: $1.6B$1.6BFY2022FY2023: $1.1B$1.1BFY2023FY2024: $602.5M$602.5MFY2024FY2025: $385.8M$385.8MFY2025

From MED's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Oct 26). Last 12 months adds up the four latest quarters.

Next report
Feb 16
Estimated date · After the close
Reported EPS
-$1.57
Quarter ended Sep 2026
Year ago EPS
-$0.21
Same quarter last year
Revenue
$72.0M
−19.4% vs a year ago
Estimates and implied move
Consensus forecasts and the move options price in
EPS by quarter (GAAP)
Dec 2024: $0.07Dec '24Mar 2025: -$0.07Mar '25Jun 2025: $0.22Jun '25Sep 2025: -$0.21Sep '25Dec 2025: -$1.65Dec '25Mar 2026: -$0.19Mar '26Jun 2026: -$0.28Jun '26Sep 2026: -$1.57Sep '26Latest -$1.57
Revenue by quarter
Dec 2024: $119.0MDec '24Mar 2025: $115.7MMar '25Jun 2025: $105.6MJun '25Sep 2025: $89.4MSep '25Dec 2025: $75.1MDec '25Mar 2026: $76.0MMar '26Jun 2026: $76.4MJun '26Sep 2026: $72.0MSep '26Latest $72.0M
How MED moved after its last 8 reports
Average move the session after a report ±9.5%
Oct 26, 2026Time not announced+2.0%
Aug 3, 2026After the close+34.3%
May 4, 2026After the close+22.5%
Feb 17, 2026After the close−0.8%
Nov 3, 2025After the close+0.8%
Aug 4, 2025After the close−3.3%
Apr 28, 2025After the close−0.6%
Feb 18, 2025After the close−11.4%
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha's call on MEDStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in

Technical Analysis

MED · as of the Nov 20 close · updated each morning
Pullback inside a longer uptrend

The stock is 7% below its 20 day and 3% below its 50 day average. It is 3% above its 200 day average, so the longer trend is still up. Momentum is weak (RSI 39). The nearest support is the swing low (Sep 18) at $11.73, and the nearest resistance the swing high (Oct 6) at $11.86.

Short trendBearish
Long trendBullish
MomentumWeak
StretchNormal
VolatilityNormal, 3.9%/day
Key levels
$13.6352 week high+16.0%
$12.5620 day average+6.9%
$12.1250 day average+3.1%
$12.05Pivot R1+2.6%
$11.86Swing high (Oct 6)+0.9%
$11.75Last close
$11.73Swing low (Sep 18)−0.2%
$11.70100 day average−0.4%
$11.68Pivot−0.6%
$11.40200 day average−3.0%
$11.39Pivot S1−3.1%
$9.2252 week low−21.5%
Indicators
RSI (14)39.46Weak, oversold below 30Neutral
MACD0.02Below its signal lineBearish
Stochastic13.6Near the bottom of its rangeOversold
ADX (14)24.4Weak trend
Williams %R-81.4Oversold below −80, overbought above −20Oversold
CCI (20)-176.7Oversold below −100, overbought above 100Oversold
Rate of change−8.3%Change over 10 sessionsBearish
ATR (14)$0.46Typical daily range, 3.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Above
MA 200Above
What happened before, for MED

What happened before

See how MED did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.

November seasonalityHow MED usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.

Seasonality

How MED has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2005.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D
Whale options flow for MEDHow many large options trades hit MED, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in

See today’s whale options flow across the market →

MED Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▼39 buying vs 62 selling
  • ●Held by funds +0.5 pts
  • ▼Funds holding -17
  • ▲Superinvestors: 3 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding96113−15.0%
In funds' top 1000–
Held by funds74.4%73.9%+0.5 pts
New / increased13 / 2625 / 43−42.6%
Reduced / sold out32 / 3028 / 24+19.2%
Put/call ratio0.030.01+143.1%
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See MED institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

MED Insider Trading

All filings →
Insider trading · 12 months
Insiders are net buyers
Bought$2.9M8 buys · 3 insiders
Sold$226K1 sale · 1 insider
100% of the selling was under pre-arranged trading plans.
2026-03 bought $179K2026-05 bought $63K2026-08 bought $1.4M2026-09 sold $226K2026-10 bought $68K2026-11 bought $1.1MDecMarJunSep
BoughtSoldlast 12 months
Trade dateInsiderTypeSharesPriceValue
Nov 19Parsa KiaiDirectorBuy94,036$12.06$1.1M
Nov 4Parsa KiaiDirectorBuy661$13.03$9K
Oct 28Parsa KiaiDirectorBuy5,557$12.24$68K
Sep 29Daniel R ChardDirectorSale plan19,089$11.85$226K
Aug 26Parsa KiaiDirectorBuy43,150$12.26$529K
Aug 24Parsa KiaiDirectorBuy4,329$12.00$52K
Every insider buy and sale for MED over 2 years, with a link to each SEC filing. AI Pro members can get an alert the moment an insider trades.See MED insider trades →

From SEC Form 4 filings by MED's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.

AI Auto Pilots

Paper trading

StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether MED is in one of them and how their past MED trades turned out.

MED in the AI portfolios
Loading…

MED News Tone and Price

Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered MED in an article yet. Here's the latest on the wider market.

MED in the news

MED Congress Trades

All congress trades →
Trades, 12 months
0
Buys
0
Sells
0
People
0
Last filed Apr 27
Who traded MED · since 2019
Latest 2 filings
$1K – $15KTraded Jun 24, 2019Filed Apr 27, 2020
$1K – $15KTraded Apr 30, 2019Filed Apr 27, 2020
PersonTypeAmountTradedFiledDelay
Donna ShalalaD · FLSell$1K – $15KJun 24, 2019Apr 27, 2020308 d
Donna ShalalaD · FLBuy$1K – $15KApr 30, 2019Apr 27, 2020363 d

From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data